2009
DOI: 10.1038/ni.1767
|View full text |Cite
|
Sign up to set email alerts
|

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells

Abstract: Interleukin 22 (IL-22) is a cytokine produced by the T(H)-17 lineage of helper T cells and NK-22 subset of natural killer cells that acts on epithelial cells and keratinocytes and has been linked to skin homeostasis and inflammation. Here we characterize a population of human skin-homing memory CD4(+) T cells that expressed the chemokine receptors CCR10, CCR6 and CCR4 and produced IL-22 but neither IL-17 nor interferon-gamma (IFN-gamma). Clones isolated from this population produced IL-22 only and had low or u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

41
960
4
17

Year Published

2010
2010
2016
2016

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 944 publications
(1,038 citation statements)
references
References 50 publications
41
960
4
17
Order By: Relevance
“…These data are at variance with the reduction of IL-22 reported in CD4 1 memory T cells in which RORC was silenced [31], but in agreement with the finding that Th22 clones express lower RORC levels than Th17 clones [32,33] and with the fact that lentivirus-induced expression of RORgt in human naïve T cells results in IL-17 without IL-22 production [5]. In this respect, it is important to note that whole genome transcritpome analysis of T-cell clones with preferential IL-22 production pointed to the preferential expression of BNC2 and FOXO4 transcription factors when compared to Th1, Th2 and Th17 cell clones [33].…”
Section: Discussionsupporting
confidence: 88%
See 2 more Smart Citations
“…These data are at variance with the reduction of IL-22 reported in CD4 1 memory T cells in which RORC was silenced [31], but in agreement with the finding that Th22 clones express lower RORC levels than Th17 clones [32,33] and with the fact that lentivirus-induced expression of RORgt in human naïve T cells results in IL-17 without IL-22 production [5]. In this respect, it is important to note that whole genome transcritpome analysis of T-cell clones with preferential IL-22 production pointed to the preferential expression of BNC2 and FOXO4 transcription factors when compared to Th1, Th2 and Th17 cell clones [33].…”
Section: Discussionsupporting
confidence: 88%
“…Human lymphocytes may, however, behave differently and in a recent report AHR agonists appear to favor IL-22 but not IL-17 production [31]. These cells have been named Th22 cells and are thought to be involved in skin immunosurveillance and skin immunopathology [32,33].In the current study, we investigated the effect of synthetic and natural AHR ligands on the production of the human T helper signature-cytokines IL-17A, IFN-g and IL-22. We found that AHR ligands decrease Th17 polarization and favor the differentiation of a subset of CD4 1 T cells that produce IL-22 independently from IL-17A or IFN-g.…”
mentioning
confidence: 94%
See 1 more Smart Citation
“…Moreover, after bleomycin administration, the majority of IL-22-expressing cells in the lung coexpresses IL-17A and promotes inflammation [44]. In contrast, subsets of gut-resident NK cells and skin-resident CD4 1 T cells were reported to express IL-22 but do not coexpress IL-17 [17,[45][46][47] and appear to contribute to a constitutive tissue-protective role in mouse models of inflammation of the intestine or skin. Collectively, these reports suggest that the production of IL-22 in the absence of IL-17 is important in promoting tissueprotective responses.…”
Section: Discussionmentioning
confidence: 99%
“…L'IL-22 était considérée comme étant la caractéristique des lymphocytes Th17, jusqu'à ce que deux études [49,50] Concernant les inhibiteurs de la signalisation, un essai de phase III évaluant l'efficacité dans le psoriasis en plaques modéré à sévère du tofacitinib, un inhibiteur de JAK (Janus kinase) 1 et JAK3 (des kinases impliquées dans les voies JAK/STAT de signalisation en aval de nombreux récepteurs de cytokines), a montré un effet équivalent de la molécule par rapport au récepteur soluble au TNF-α, l'étanercept, et sa supériorité par rapport au placebo [48].…”
Section: Perspectives : Inhibition De L'interleukine 22unclassified